Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'END-POINTS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 349 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kim, YC; Fisher, ME
      The critical locus of a simple fluid with added salt

      JOURNAL OF PHYSICAL CHEMISTRY B
    2. Perreault, SD; Cancel, AM
      Significance of incorporating measures of sperm production and function into rat toxicology studies

      REPRODUCTION
    3. Marty, MS; Crissman, JW; Carney, EW
      Evaluation of the male pubertal assay's ability to detect thyroid inhibitors and dopaminergic agents

      TOXICOLOGICAL SCIENCES
    4. Soller, BR; Cingo, N; Puyana, JC; Khan, T; Hsi, C; Kim, H; Favreau, J; Heard, SO
      Simultaneous measurement of hepatic tissue pH, venous oxygen saturation and hemoglobin by near infrared spectroscopy

      SHOCK
    5. Morreim, EH
      Result-based compensation in health care: A good, but limited, idea

      JOURNAL OF LAW MEDICINE & ETHICS
    6. Packer, M
      Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure

      JOURNAL OF CARDIAC FAILURE
    7. Schmid, F; Wilding, NB
      Wetting of a symmetrical binary fluid mixture on a wall - art. no. 031201

      PHYSICAL REVIEW E
    8. Becker, NG; Marschner, IC
      Advances in medical statistics arising from the AIDS epidemic

      STATISTICAL METHODS IN MEDICAL RESEARCH
    9. Dowling, AJ; Panzarella, T; Ernst, DS; Neville, AJ; Moore, MJ; Tannock, IF
      A retrospective analysis of the relationship between changes in serum PSA,palliative response and survival following systemic treatment in a Canadian randomized trial for symptomatic hormone-refractory prostate cancer

      ANNALS OF ONCOLOGY
    10. Oudard, S; Caty, A; Humblet, Y; Beauduin, M; Suc, E; Piccart, M; Rolland, F; Fumoleau, P; Bugat, R; Houyau, P; Monnier, A; Sun, X; Montcuquet, P; Breza, J; Novak, J; Gil, T; Chopin, D
      Phase II study of vinorelbine in patients with androgen-independent prostate cancer

      ANNALS OF ONCOLOGY
    11. Bender, R; Lange, S
      Adjusting for multiple testing - when and how?

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    12. Zhao, C; Vodicka, P; Sram, RJ; Hemminki, K
      DNA adducts of 1,3-butadiene in humans: Relationships to exposure, GST genotypes, single-strand breaks, and cytogenetic end points

      ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
    13. Sinibaldi, VJ; Arzoomanian, RZ
      Clinical conduct and nursing quality of life in prostate cancer

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    14. Sibley, PK; Ankley, GT; Benoit, DA
      Factors affecting reproduction and the importance of adult size on reproductive output of the midge Chironomus tentans

      ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
    15. Anderson, GL; Boyd, WA; Williams, PL
      Assessment of sublethal endpoints for toxicity testing with the nematode Caenorhabditis elegans

      ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
    16. Lesko, LJ; Atkinson, AJ
      Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: Criteria, validation, strategies

      ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
    17. Fan, M; Marks, LB; Lind, P; Hollis, D; Woel, RT; Bentel, GG; Anscher, MS; Shafman, TD; Coleman, RE; Jaszczak, RJ; Munley, MT
      Relating radiation-induced regional lung injury to changes in pulmonary function tests

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    18. Heidenreich, A; von Knobloch, R; Hofmann, R
      Current status of cytotoxic chemotherapy in hormone refractory prostate cancer

      EUROPEAN UROLOGY
    19. Nygren, P; Glimelius, B
      The Swedish Council on Technology Assessment in Health Care (SBU) report on cancer chemotherapy - Project objectives, the working process, key definitions and general aspects on cancer trial methodology and interpretation

      ACTA ONCOLOGICA
    20. McMahon, RP; Harrell, FE
      Joint testing of mortality and a non-fatal outcome in clinical trials

      STATISTICS IN MEDICINE
    21. Li, ZQ; Meredith, MP; Hoseyni, MS
      A method to assess the proportion of treatment effect explained by a surrogate endpoint

      STATISTICS IN MEDICINE
    22. Lumley, T; Simes, RJ; Gebski, V; Hudson, HM
      Combining components of quality of life to increase precision and evaluatetrade-offs

      STATISTICS IN MEDICINE
    23. Willan, AR; O'Brien, BJ; Leyva, RA
      Cost-effectiveness analysis when the WTA is greater than the WTP

      STATISTICS IN MEDICINE
    24. Molenberghs, G; Geys, H; Buyse, M
      Evaluation of surrogate endpoints in randomized experiments with mixed discrete and continuous outcomes

      STATISTICS IN MEDICINE
    25. Willan, AR; Lin, DY
      Incremental net benefit in randomized clinical trials

      STATISTICS IN MEDICINE
    26. Jarvelainen, HA; Orpana, A; Perola, M; Savolainen, VT; Karhunen, PJ; Lindros, KO
      Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factorfor alcoholic liver disease

      HEPATOLOGY
    27. De Gruttola, VG; Clax, P; DeMets, DL; Downing, GJ; Ellenberg, SS; Friedman, L; Gail, MH; Prentice, R; Wittes, J; Zeger, SL
      Considerations in the evaluation of surrogate endpoints in clinical trials: Summary of a National Institutes of Health Workshop

      CONTROLLED CLINICAL TRIALS
    28. Willan, AR
      Analysis, sample size, and fewer for estimating incremental net health benefit from clinical trial data

      CONTROLLED CLINICAL TRIALS
    29. Rahlfs, VW
      Untitled

      CONTROLLED CLINICAL TRIALS
    30. Anderson, WF; Hawk, E; Berg, CD
      Secondary chemoprevention of upper aerodigestive tract tumors

      SEMINARS IN ONCOLOGY
    31. Kucuk, O; Fisher, E; Moinpour, CM; Coleman, D; Hussain, MHA; Sartor, AO; Chatta, GS; Lowe, BA; Eisenberger, MA; Crawford, ED
      Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: A Southwest Oncology Group Study (SWOG 9235)

      UROLOGY
    32. Lee, JD; Lieberman, R; Sloan, JA; Piantadosi, S; Lippman, SM
      Design considerations for efficient prostate cancer chemoprevention trials

      UROLOGY
    33. Trock, BJ
      Validation of surrogate endpoint biomarkers in prostate cancer chemoprevention trials

      UROLOGY
    34. Law, BM
      Wetting, adsorption and surface critical phenomena

      PROGRESS IN SURFACE SCIENCE
    35. Nishimura, K; Nonomura, N; Ono, Y; Nozawa, M; Fukui, T; Harada, Y; Imazu, T; Takaha, N; Sugao, H; Miki, T; Okuyama, A
      Oral combination of cyclophosphamide, uracil plus tegafur and estramustinefor hormone-refractory prostate cancer

      ONCOLOGY
    36. Kim, YC; Fisher, ME; Barbosa, MC
      Isothermal binodal curves near a critical endpoint

      JOURNAL OF CHEMICAL PHYSICS
    37. Ahn, YJ
      Conic approximation of planar curves

      COMPUTER-AIDED DESIGN
    38. Atkinson, AJ; Colburn, WA; DeGruttola, VG; DeMets, DL; Downing, GJ; Hoth, DF; Oates, JA; Peck, CC; Schooley, RT; Spilker, BA; Woodcock, J; Zeger, SL
      Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    39. Sherman, EJ; Pfister, DG; Ruchlin, HS; Rubin, DM; Radzyner, MH; Kelleher, GH; Slovin, SF; Kelly, WK; Scher, HI
      The collection of indirect and nonmedical direct costs (COIN) form - A newtool for collecting the invisible costs of androgen independent prostate carcinoma

      CANCER
    40. Thornhill, J; Corbett, D
      Therapeutic implications of hypothermic and hyperthermic temperature conditions in stroke patients

      CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    41. Hellmich, M
      Monitoring clinical trials with multiple arms

      BIOMETRICS
    42. Xu, J; Zeger, SL
      The evaluation of multiple surrogate endpoints

      BIOMETRICS
    43. Holbrook, JT; Meinert, CL; Van Natta, ML; Davis, M; Hubbard, L; Jabs, DA
      Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients

      ARCHIVES OF OPHTHALMOLOGY
    44. Glynn, P
      Solid-solution solubilities and thermodynamics: Sulfates, carbonates and halides

      SULFATE MINERALS - CRYSTALLOGRAPHY, GEOCHEMISTRY AND ENVIRONMENTAL SIGNIFICANCE
    45. Williams, PL; Anderson, GL; Johnstone, JL; Nunn, AD; Tweedle, MF; Wedeking, P
      Caenorhabditis elegans as an alternative animal species

      JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A
    46. Lubsen, J; Poole-Wilson, PA
      Risk management in cardiology

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    47. Gamsjager, H; Konigsberger, E; Preis, W
      Lippmann diagrams: Theory and application to carbonate systems

      AQUATIC GEOCHEMISTRY
    48. Huan, SD; Natale, RB; Stewart, DJ; Sartiano, GP; Stella, PJ; Roberts, JD; Symes, AL; Finizio, M
      A multicenter phase II trial of losoxantrone (DuP-941) in hormone-refractory metastatic prostate cancer

      CLINICAL CANCER RESEARCH
    49. Lippman, SM; Matrisian, LM
      Protease inhibitors in oral carcinogenesis and chemoprevention

      CLINICAL CANCER RESEARCH
    50. Zhang, SP; Karunamuni, RJ
      On nonparametric density estimation at the boundary

      JOURNAL OF NONPARAMETRIC STATISTICS
    51. Begg, CB; Leung, DHY
      On the use of surrogate end points in randomized trials

      JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY
    52. Moinpour, CM; Lyons, B; Schmidt, SP; Chansky, K; Patchell, RA
      Substituting proxy ratings for patient ratings in cancer clinical trials: An analysis based on a Southwest Oncology Group trial in patients with brain metastases

      QUALITY OF LIFE RESEARCH
    53. Gilbert, PB
      Some statistical issues in the design of HIV-1 vaccine and treatment trials

      STATISTICAL METHODS IN MEDICAL RESEARCH
    54. Duncan, GG; Philips, N; Pickles, T
      Report on the quality of life analysis from the phase III trial of pion versus photon radiotherapy in locally advanced prostate cancer

      EUROPEAN JOURNAL OF CANCER
    55. Haguenauer, D; Welch, V; Shea, B; Tugwell, P; Adachi, JD; Wells, G
      Fluoride for the treatment of postmenopausal osteoporotic fractures: A meta-analysis

      OSTEOPOROSIS INTERNATIONAL
    56. Morant, R; Bernhard, J; Maibach, R; Borner, M; Fey, MF; Thurlimann, B; Jacky, E; Trinkler, F; Bauer, J; Zulian, G; Hanselmann, S; Hurny, C; Hering, F
      Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma

      ANNALS OF ONCOLOGY
    57. Culine, S; Droz, JP
      Chemotherapy in advanced androgen-independent prostate cancer 1990-1999: Adecade of progress?

      ANNALS OF ONCOLOGY
    58. Son, HY; Nishikawa, A; Ikeda, T; Nakamura, H; Miyauchi, M; Imazawa, T; Furukawa, F; Hirose, M
      Lack of modifying effects of environmental estrogenic compounds on the development of thyroid proliferative lesions in male rats pretreated with N-bis(2-hydroxypropyl)nitrosamine (DHPN)

      JAPANESE JOURNAL OF CANCER RESEARCH
    59. Moreira, ELT; de Camargo, JLV; Rodrigues, MAM; Barbisan, LF; Salvadori, DMD
      Dose- and sex-related carcinogenesis by N-bis(2-hydroxypropyl)nitrosamine in Wistar rats

      JAPANESE JOURNAL OF CANCER RESEARCH
    60. Son, HY; Nishikawa, A; Ikeda, T; Furukawa, F; Hirose, M
      Lack of modification by environmental estrogenic compounds of thyroid carcinogenesis in ovariectomized rats pretreated with N-bis(2-hydroxypropyl)nitrosamine (DHPN)

      JAPANESE JOURNAL OF CANCER RESEARCH
    61. Schouten, HJA
      Combined evidence from multiple outcomes in a clinical trial

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    62. Hawk, ET; Lippman, SM
      Primary cancer prevention trials

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    63. Kramer, BS; Brawley, OW
      Cancer screening

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    64. Schatzkin, A
      Intermediate markers as surrogate endpoints in cancer research

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    65. Cooley, ME
      Symptoms in adults with lung cancer: A systematic research review

      JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
    66. Psaty, BM; Rhoads, C; Furberg, CD
      Evidence-based medicine - Worship of form and treatment of high blood pressure

      JOURNAL OF GENERAL INTERNAL MEDICINE
    67. Dhawan, R; Dusenbery, DB; Williams, PL
      A comparison of metal-induced lethality and behavioral responses in the nematode Caenorhabditis elegans

      ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
    68. Meyer, R
      Aesthetic refinements in nose reconstruction

      AESTHETIC PLASTIC SURGERY
    69. Hyman, JB; Leibowitz, SG
      A general framework for prioritizing land units for ecological protection and restoration

      ENVIRONMENTAL MANAGEMENT
    70. Holm, C; Melcer, B; Horbrand, F; Worl, HH; von Donnersmarck, GH; Muhlbauer, W
      Haemodynamic and oxygen transport responses in survivors and non-survivorsfollowing thermal injury

      BURNS
    71. D'Agostino, RB
      Controlling alpha in a clinical trial: the case for secondary endpoints

      STATISTICS IN MEDICINE
    72. Koch, GG
      Discussion for 'Alpha calculus in clinical trials: considerations and commentary for the new millennium'

      STATISTICS IN MEDICINE
    73. O'Neill, RT
      Commentary on 'Alpha calculus in clinical trials: considerations and commentary for the new millennium'

      STATISTICS IN MEDICINE
    74. Bolland, K; Whitehead, J
      Formal approaches to safety monitoring of clinical trials in life-threatening conditions

      STATISTICS IN MEDICINE
    75. Colbourne, F; Corbett, D; Zhao, ZH; Yang, J; Buchan, AM
      Prolonged but delayed postischemic hypothermia: A long-term outcome study in the rat middle cerebral artery occlusion model

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    76. Walker, AS; Babiker, AG; Darbyshire, JH
      Analysis of multivariate failure-time data from HIV clinical trials

      CONTROLLED CLINICAL TRIALS
    77. Prescott, CA; Kendler, KS
      Influence of ascertainment strategy on finding sex differences in genetic estimates from twin studies of alcoholism

      AMERICAN JOURNAL OF MEDICAL GENETICS
    78. Sebille, V; Bellissant, E
      Comparison of four sequential methods allowing for early stopping of comparative clinical trials

      CLINICAL SCIENCE
    79. Buyse, M; Thirion, P; Carlson, RW; Burzykowski, T; Molenberghs, G; Piedbois, P
      Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis

      LANCET
    80. Peredney, CL; Williams, PL
      Utility of Caenorhabditis elegans for assessing heavy metal contamination in artificial soil

      ARCHIVES OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY
    81. Ivatury, RR; Sugerman, H
      In quest of optimal resuscitation: Tissue specific, on to the microcirculation

      CRITICAL CARE MEDICINE
    82. Ivanov, R; Allen, J; Calvin, JE
      The incidence of major morbidity in critically ill patients managed with pulmonary artery catheters: A meta-analysis

      CRITICAL CARE MEDICINE
    83. DeMets, DL
      The role of surrogate outcome measures in evaluating medical devices

      SURGERY
    84. Cramer, SC; Bastings, EP
      Mapping clinically relevant plasticity after stroke

      NEUROPHARMACOLOGY
    85. Caracciolo, S; Causo, MS; Ferraro, G; Papinutto, M; Pelissetto, A
      Bilocal dynamics for self-avoiding walks

      JOURNAL OF STATISTICAL PHYSICS
    86. Nishimura, K; Nonomura, N; Yasunaga, Y; Takaha, N; Inoue, H; Sugao, H; Yamaguchi, S; Ukimura, O; Miki, T; Okuyama, A
      Low doses of oral dexamethasone for hormone-refractory prostate carcinoma

      CANCER
    87. Bracarda, S; Tonato, M; Rosi, P; De Angelis, V; Mearini, E; Cesaroni, S; Fornetti, P; Porena, M
      Oral estramustine and cyclophosphamide in patients with metastatic hormonerefractory prostate carcinoma - A phase II study

      CANCER
    88. Dawson, NA; Conaway, M; Halabi, S; Winer, EP; Small, EJ; Lake, D; Vogelzang, NJ
      A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma - Cancer and leukemia group B study 9181

      CANCER
    89. Vicini, FA; Kestin, LL; Martinez, AA
      The correlation of serial prostate specific antigen measurements with clinical outcome after external beam radiation therapy of patients for prostatecarcinoma

      CANCER
    90. Culine, S
      News on the medical treatment of urological tumors

      BULLETIN DU CANCER
    91. Ball, MJ; Ackland, ML
      Zinc intake and status in Australian vegetarians

      BRITISH JOURNAL OF NUTRITION
    92. Rosenthal, MA
      Advances in the management of prostate cancer

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE
    93. Velmahos, GC; Demetriades, D; Shoemaker, WC; Chan, LS; Tatevossian, R; Wo, CCJ; Vassiliu, P; Cornwell, EE; Murray, JA; Roth, B; Belzberg, H; Asensio, JA; Berne, TV
      Endpoints of resuscitation of critically injured patients: Normal or supranormal? A prospective randomized trial

      ANNALS OF SURGERY
    94. Auclerc, G
      Systemic therapy in metastatic prostate cancer

      ANNALES D UROLOGIE
    95. Polonen, P; Ruokonen, E; Hippelainen, M; Poyhonen, M; Takala, J
      A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients

      ANESTHESIA AND ANALGESIA
    96. Shapiro, MB; Jenkins, DH; Schwab, CW; Rotondo, MF
      Damage control: Collective review

      JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
    97. Porter, JM
      Maintaining survivors' values of left ventricular power output during shock resuscitation: A prospective pilot study - Editorial comment

      JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
    98. Calin, A; Nakache, JP; Gueguen, A; Zeidler, H; Mielants, H; Dougados, M
      Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?

      RHEUMATOLOGY
    99. Bonassi, S
      Combining environmental exposure and genetic effect measurements in healthoutcome assessment

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    100. Muller, HG; Stadtmuller, U
      Multivariate boundary kernels and a continuous least squares principle

      JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/02/20 alle ore 23:44:37